{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:09:15Z","timestamp":1777694955465,"version":"3.51.4"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061565","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T17:08:14Z","timestamp":1366391294000},"page":"e61565","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Wen-Yee","family":"Chay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hock","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whee-Sze","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inny","family":"Busmanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharyl","family":"Thung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheow- Lei","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Kuei","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Nin","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lay-Tin","family":"Soh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tew-Hong","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Kuie","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Kim","family":"Lim-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiat-Hon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Whay-Kuang","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Kee","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0046-8177(00)80020-9","article-title":"Ovarian serous borderline tumors: the citadel defended","volume":"31","author":"RJ Kurman","year":"2000","journal-title":"Hum Pathol"},{"key":"ref2","article-title":"Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates","author":"AHT Gurung","year":"2012","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2004.08.078","article-title":"Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment","volume":"22","author":"V Hess","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2004.12.056","article-title":"Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"97","author":"D Pectasides","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.4088","article-title":"Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas","volume":"229","author":"MS Anglesio","year":"2013","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/jclinpath-2011-200082","article-title":"Dual-colour HER2\/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours","volume":"64","author":"B Yan","year":"2011","journal-title":"J Clin Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1755-8794-5-47","article-title":"Histotype-specific copy-number alterations in ovarian cancer","volume":"5","author":"RY Huang","year":"2012","journal-title":"BMC Med Genomics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target","volume":"19","author":"C Gravalos","year":"2008","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","article-title":"A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets","volume":"61","author":"N Deng","year":"2012","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"YJ Bang","year":"2010","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a HER2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"M Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1471-2407-9-433","article-title":"HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy","volume":"9","author":"JN McAlpine","year":"2009","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-010-0952-2","article-title":"HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing","volume":"457","author":"J Ruschoff","year":"2010","journal-title":"Virchows Arch"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"480 e481","DOI":"10.1016\/j.ajog.2011.06.049","article-title":"Natural history and outcome of mucinous carcinoma of the ovary","volume":"205","author":"MB Schiavone","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/ijc.26235","article-title":"Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study","volume":"130","author":"IT Gram","year":"2012","journal-title":"Int J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jclinpath-2011-200616","article-title":"HER2 expression in ovarian carcinoma: caution and complexity in biomarker analysis","volume":"65","author":"H McCaughan","year":"2012","journal-title":"J Clin Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"J Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-7-134","article-title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","volume":"7","author":"M Tischkowitz","year":"2007","journal-title":"BMC Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000331643","article-title":"Triple-Negative Breast Cancer: Clinical and Histological Correlations","volume":"6","author":"Z Elsawaf","year":"2011","journal-title":"Breast Care (Basel)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.2112","article-title":"Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours","volume":"211","author":"L Khalique","year":"2007","journal-title":"J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T17:27:09Z","timestamp":1562952429000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061565"}},"subtitle":[],"editor":[{"given":"Ramon Andrade","family":"de Mello","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}